Cx Precision Medicine develops the NeuroFirst™ Memory test, a blood-based diagnostic tool that utilizes proteomics and artificial intelligence to assess memory complaints in individuals over 60. This test enables primary care physicians to accurately rule out dementia and identify patients who may require further neurological evaluation, leading to earlier and more targeted treatment options.
Funding
Funding not disclosed
Founders
Product
Problem
Diagnosing the cause of memory complaints in individuals over 60 is challenging for primary care physicians. Current methods often lead to delayed or inaccurate diagnoses of neurodegenerative disorders like Alzheimer's disease and Parkinson's disease. This can result in delayed treatment and increased healthcare costs.
Solution
Cx Precision Medicine offers the NeuroFirst™ Memory test, a blood-based diagnostic tool that assists primary care physicians in assessing memory complaints in patients aged 60 and older. The test utilizes proteomics and artificial intelligence to analyze a panel of proteins in the blood, providing an objective measure of memory impairment. By accurately ruling out dementia and identifying patients who may require further neurological evaluation, NeuroFirst™ Memory enables earlier and more targeted treatment decisions. This approach aims to improve patient outcomes, reduce unnecessary referrals, and lower overall healthcare expenses associated with dementia diagnosis and management. The company is also developing NeuroFirst™ Parkinson's test to help primary care physicians identify patients who should be further evaluated for Parkinson's Disease.
Target Audience
The primary target audience is primary care physicians who need a reliable and objective tool to assess memory complaints in their older adult patients.
Features
- Blood-based test for assessing memory complaints in individuals aged 60 and over
- Proteomics-based analysis of a panel of proteins in blood samples
- Artificial intelligence algorithms trained on thousands of samples to generate results
- Assists in ruling out dementia and identifying patients who may benefit from further neurological evaluation
- Provides objective data to support clinical decision-making in primary care settings